ARTG 325940AXONICS SNM SYSTEM™ Tined Lead 2201 - Sacral plexus percutaneous incontinence-control electrical stimulation system electrode
ARTG ID: 325940 · Axonics Modulation Technologies Australia Pty Ltd · Axonics Inc · Class III · Started November 06, 2019
Good Name: Axonics Modulation Technologies Australia Pty Ltd - AXONICS SNM SYSTEM™ Tined Lead 2201 - Sacral plexus percutaneous incontinence-control electrical stimulation system electrode
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 325940
- Start Date
- November 06, 2019
- Effective Date
- November 06, 2019
- Name
- Axonics Inc
- Country
- United States of America
- Address
- 26 Technology Drive, Irvine, California, 92618
The AXONICS SNM SYSTEM™ Tined Lead is an implantable accessory to the nonimplantable AXONICS SNM SYSTEM Trial Stimulator and to the Axonics Neurostimulator AIMD, both of which are intended to treat urinary and/or faecal incontinence. The tined lead connects to a stimulation device, which creates a series of electrical pulses to stimulate the sacral nerve. The tined lead kit includes accessories used during implantation of the tined lead.
Access comprehensive regulatory information for AXONICS SNM SYSTEM™ Tined Lead 2201 - Sacral plexus percutaneous incontinence-control electrical stimulation system electrode in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 325940 and sponsored by Axonics Modulation Technologies Australia Pty Ltd, manufactured by Axonics Inc in United States of America. The device registration started on November 06, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.